Get startedLog in
    Picture of Canafarma Hemp Products logo

    CNFA — Canafarma Hemp Products Income Statement

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareAdventurousMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Canafarma Hemp Products, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

    2017
    June 30th
    2018
    June 30th
    2019
    June 30th
    2020
    June 30th
    Period Length:12 M12 M12 M12 M
    Source:ARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    Status:
    fx
    Final
    fx
    Final
    fx
    Final    		Final
    Revenue
    Total Revenue0001.8
    Cost of Revenue
    Gross Profit———-1.12
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses0.0010.0070.02619
    Operating Profit-0.001-0.007-0.026-17.2
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-0.001-0.007-0.026-19
    Provision for Income Taxes
    Net Income After Taxes-0.001-0.007-0.026-19
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-0.001-0.007-0.026-17.8
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-0.001-0.007-0.026-17.8
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0-0-0-0.081
    Dividends per Share